Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Intravenous thrombolysis remains a standard treatment for acute ischemic stroke within 4.5 hours after onset. Vascular ...

"Novartis’ Cosentyx shows no benefit in Phase III GCA trial" was originally created and published by Clinical Trials Arena, a ...

Europe’s economy is buckling under the pressure of climate regulation. Now the European Commission has signaled it may gradually revise its targets. The industrial math in Germany is unforgiving.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

In a functioning system, the kind of placebo-controlled vaccine trials that Secretary Kennedy is calling for would never get ...

Compared with placebo, pramipexole added to antidepressants reduces symptoms significantly at 12 weeks in treatment-resistant depression, a trial finds.

Erenumab is not associated with significant reductions in weekly attacks in patients with chronic cluster headache vs placebo ...

Novartis is falling farther behind AbbVie, which expanded its JAK inhibitor Rinvoq into giant cell arteritis in April.

Both regulatory-approved and pipeline treatments for moderate to severe hidradenitis suppurativa demonstrate comparable ...

Explore innovative clinical trial design with digital twins, enhancing predictions while reducing costs and efforts in ...